Methyl-cellulose powder for prevention and management of nasal symptoms.

about

Benefits of Nasal Cellulose Powder Application Depend on the Type of Allergen Sensitization in Allergic Rhinitis.

P2860

Q50144860-1D1D78CA-185C-41E7-BCEE-145ABE07ECCE

P2860

Methyl-cellulose powder for prevention and management of nasal symptoms.

Item

http://www.wikidata.org/entity/Q39150448

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Methyl-cellulose powder for prevention and management of nasal symptoms.

@en

Methyl-cellulose powder for prevention and management of nasal symptoms.

@nl

type

Item

label

Methyl-cellulose powder for prevention and management of nasal symptoms.

@en

Methyl-cellulose powder for prevention and management of nasal symptoms.

@nl

prefLabel

Methyl-cellulose powder for prevention and management of nasal symptoms.

@en

Methyl-cellulose powder for prevention and management of nasal symptoms.

@nl

P1476

Methyl-cellulose powder for prevention and management of nasal symptoms.

@en

P2093

Jean Emberlin

http://www.w3.org/2001/XMLSchema#string

Martin Church

http://www.w3.org/2001/XMLSchema#string

Natalia I Ilyina

http://www.w3.org/2001/XMLSchema#string

Nikolai P Nikitin

http://www.w3.org/2001/XMLSchema#string

Nils Åberg

http://www.w3.org/2001/XMLSchema#string

Peter Josling

http://www.w3.org/2001/XMLSchema#string

P2860

A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US

Allergic rhinitis and its impact on asthma.

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).

Liposomes: a new non-pharmacological therapy concept for seasonal-allergic-rhinoconjunctivitis.

Safety assessment of hydroxypropyl methylcellulose as a food ingredient.

Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN.

United airways concept: what does it teach us about systemic inflammation in airways disease?

Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.

Barrier-enforcing measures as treatment principle in allergic rhinitis: a systematic review.

Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.

P304

885-892

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17476348.2017.1375408

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Todor Popov

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28862062

http://www.w3.org/2001/XMLSchema#string

P921

cellulose

Methyl-cellulose powder for prevention and management of nasal symptoms.

about

P2860

P2860

Methyl-cellulose powder for prevention and management of nasal symptoms.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921